On the other hand, the absence of dystrophin – as in DMD or the mdx model – has consistently revealed an upregulation in the α7 integrin, thought to be a compensatory mechanism, although this compensation appears insufficient long-term in DMD patients144–147. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.